Back
Day Range
$22.31
$22.31
52-Week Range
$16.35
$25.69
Volume
252
50D / 200D Avg
$21.51
/
$20.84
Prev Close
$22.31
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 34.7 | 0.3 |
| P/B | 6.9 | 2.9 |
| ROE % | 20.7 | 3.7 |
| Net Margin % | 29.5 | 3.8 |
| Rev Growth 5Y % | -10.0 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$23.65
+6.0%
Low: $21.30
High: $26.00
Forward P/E
28.2
Forward EPS
$0.79
EPS Growth (est.)
+0.0%
Est. Revenue
2.3 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.13
$0.12 – $0.13
|
3.3 B | 1 |
| FY2029 |
$1.25
$1.22 – $1.28
|
3.1 B | 1 |
| FY2028 |
$1.07
$1.04 – $1.09
|
2.8 B | 1 |
Key Takeaways
Revenue declined -9.96% annually over 5 years
Earnings grew 184.46% over the past year
ROE of 20.67% indicates high profitability
Net margin of 29.46% shows strong profitability
Debt/Equity of 0.08 — conservative balance sheet
Generating 445.60M in free cash flow
Growth
Revenue Growth (5Y)
-9.96%
Revenue (1Y)-27.18%
Earnings (1Y)184.46%
FCF Growth (3Y)307.00%
Quality
Return on Equity
20.67%
ROIC-13.62%
Net Margin29.46%
Op. Margin-28.98%
Safety
Debt / Equity
0.08
Current Ratio1.87
Interest Coverage-33.42
Valuation
P/E Ratio
34.73
P/B Ratio6.93
EV/EBITDAN/A
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -27.18% | Revenue Growth (3Y) | -10.23% |
| Earnings Growth (1Y) | 184.46% | Earnings Growth (3Y) | 22.76% |
| Revenue Growth (5Y) | -9.96% | Earnings Growth (5Y) | -7.90% |
| Profitability | |||
| Revenue (TTM) | 1.28B | Net Income (TTM) | 377.20M |
| ROE | 20.67% | ROA | 14.79% |
| Gross Margin | 41.41% | Operating Margin | -28.98% |
| Net Margin | 29.46% | Free Cash Flow (TTM) | 445.60M |
| ROIC | -13.62% | FCF Growth (3Y) | 307.00% |
| Safety | |||
| Debt / Equity | 0.08 | Current Ratio | 1.87 |
| Interest Coverage | -33.42 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 34.73 | P/B Ratio | 6.93 |
| P/S Ratio | 10.23 | PEG Ratio | 0.26 |
| EV/EBITDA | N/A | Dividend Yield | 0.01% |
| Market Cap | 13.10B | Enterprise Value | 12.99B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.28B | 1.76B | 1.59B | 1.64B | 1.95B |
| Net Income | 377.20M | 132.60M | 250.30M | 376.90M | 524.20M |
| EPS (Diluted) | 0.64 | 0.23 | 0.43 | 0.65 | 0.91 |
| Gross Profit | 530.20M | 1.06B | 945.90M | 1.01B | 1.22B |
| Operating Income | -371.00M | 254.40M | 334.70M | 509.10M | 723.20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.55B | 2.28B | 2.20B | 2.11B | 2.08B |
| Total Liabilities | 660.40M | 522.60M | 451.10M | 427.30M | 554.10M |
| Shareholders' Equity | 1.89B | 1.76B | 1.75B | 1.68B | 1.52B |
| Total Debt | 153.30M | 189.10M | 145.80M | 104.30M | 118.40M |
| Cash & Equivalents | 264.50M | 82.00M | 121.00M | 89.90M | 97.30M |
| Current Assets | 935.40M | 704.90M | 774.20M | 887.90M | 920.00M |
| Current Liabilities | 500.40M | 385.00M | 289.80M | 303.90M | 427.50M |